Cystagon is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Mylan Pharmaceuticals Inc.. The primary component is Cysteamine Bitartrate.
| Product ID | 0378-9045_263f8238-b6bd-42fa-b339-f27ede4026e2 |
| NDC | 0378-9045 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Cystagon |
| Generic Name | Cysteamine Bitartrate |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2005-04-11 |
| Marketing End Date | 2030-01-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020392 |
| Labeler Name | Mylan Pharmaceuticals Inc. |
| Substance Name | CYSTEAMINE BITARTRATE |
| Active Ingredient Strength | 150 mg/1 |
| Pharm Classes | Cystine Depleting Agent [EPC],Cystine Disulfide Reduction [MoA] |
| NDC Exclude Flag | N |
| Marketing Start Date | 2005-04-11 |
| Marketing End Date | 2030-01-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020392 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2005-04-11 |
| Marketing Category | NDA |
| Application Number | NDA020392 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1994-08-15 |
| Marketing End Date | 2018-09-04 |
| Ingredient | Strength |
|---|---|
| CYSTEAMINE BITARTRATE | 150 mg/1 |
| SPL SET ID: | f495b76d-96c6-48e5-8fa3-30a4336628eb |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0378-9040 | Cystagon | cysteamine bitartrate |
| 0378-9045 | Cystagon | cysteamine bitartrate |
| 75987-100 | PROCYSBI | Cysteamine bitartrate |
| 75987-101 | PROCYSBI | Cysteamine bitartrate |
| 75987-140 | PROCYSBI | Cysteamine bitartrate |
| 75987-145 | PROCYSBI | Cysteamine bitartrate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() CYSTAGON 74414870 1907806 Live/Registered |
Mylan Pharmaceuticals Inc. 1993-07-21 |